TRxADE HEALTH, INC financial data

Symbol
MEDS on Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Location
2420 Brunello Trace, Lutz, Florida
State of incorporation
Delaware
Fiscal year end
December 31
Former names
TRXADE GROUP, INC. (to 5/28/2021), XCELLINK INTERNATIONAL INC. (to 1/31/2014), Bluebird Exploration Co. (to 12/10/2008)
Latest financial report
Q4 2023 - Apr 22, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 46.5 % -65.9%
Quick Ratio 12.1 % +85.9%
Debt-to-equity 266 % +34.9%
Return On Equity -623 % -187%
Return On Assets -170 % -141%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.41M shares -86.1%
Common Stock, Shares, Outstanding 905K shares +44.5%
Entity Public Float 11.5M USD -32.3%
Common Stock, Value, Issued 9 USD +50%
Weighted Average Number of Shares Outstanding, Basic 764K shares +35.3%
Weighted Average Number of Shares Outstanding, Diluted 2.38M shares +320%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.27M USD -19.3%
Cost of Revenue 5.67M USD +19.9%
General and Administrative Expense 2.79M USD +64.9%
Operating Income (Loss) -7.26M USD -149%
Nonoperating Income (Expense) -6.46M USD -1360%
Net Income (Loss) Attributable to Parent -17.8M USD -414%
Earnings Per Share, Basic -10.7 USD/shares -243%
Earnings Per Share, Diluted -7.49 USD/shares -22.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 152K USD -86.1%
Accounts Receivable, after Allowance for Credit Loss, Current 822K USD +30.5%
Inventory, Net 968 USD -98.5%
Assets, Current 2.75M USD +31.5%
Property, Plant and Equipment, Net 277K USD +325%
Operating Lease, Right-of-Use Asset 530K USD -49.6%
Intangible Assets, Net (Excluding Goodwill) 8.96M USD
Goodwill 5.13M USD
Assets 12.5M USD +238%
Accounts Payable, Current 2.08M USD +294%
Accrued Liabilities, Current 401K USD +47.8%
Contract with Customer, Liability, Current 996 USD -90%
Liabilities, Current 11.6M USD +438%
Operating Lease, Liability, Noncurrent 409K USD -53.9%
Other Liabilities, Noncurrent 777K USD -21.4%
Liabilities 12M USD +256%
Retained Earnings (Accumulated Deficit) -33.2M USD -68.6%
Stockholders' Equity Attributable to Parent 542K USD -28.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 542K USD +58.2%
Liabilities and Equity 12.5M USD +238%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -932K USD +6.92%
Net Cash Provided by (Used in) Financing Activities 681K USD
Net Cash Provided by (Used in) Investing Activities 333K USD +1349%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 905K shares +44.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -943K USD +53.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 734K USD +118%
Deferred Tax Assets, Valuation Allowance 5.94M USD +47.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 549K USD -48.7%
Depreciation 19.4K USD +43.7%
Lessee, Operating Lease, Liability, to be Paid 652K USD -51.2%
Operating Lease, Liability, Current 140K USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Two 193K USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year One 188K USD -36%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 103K USD -61.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 163K USD -47.6%
Deferred Tax Assets, Operating Loss Carryforwards 5.8M USD +43.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 58.3K USD -81.8%
Operating Lease, Payments 386K USD +12%
Additional Paid in Capital 33.8M USD +65%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 815K USD +1748%
Deferred Tax Assets, Net of Valuation Allowance 6.08M USD +50.8%
Interest Expense 1.2M USD +256%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%